Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy Subjects

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to see if there is an effect on the pharmacokinetics of bosutinib when administered with lansoprazole.

Key facts

Study ID

NCT00952913

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

24

Starts

2009-08-01

Expected to finish

2009-10-01

Last updated by the study team

2011-04-19

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy men and women of nonchildbearing potential, between the ages of 18 to 50 years old.

You may not qualify if…

• Any cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.

Where it is running

• Pfizer Investigational Site — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.